57934 Federal Register / Vol. 69, No. 187 / Tuesday, September 28, 2004 / Notices 

Quantitative Research 

Approximately 800 consumers who 

engaged in a mortgage transaction 

during the previous two years will 

participate in the quantitative phase of 

the research. Each copy test interview 

will take roughly 20–30 minutes. The 

estimated hours burden for the 

quantitative research ranges from 267 

hours (800 respondents × 1⁄3 hour per 

respondent) to 400 hours (800 

respondents × 1⁄2 hour per respondent). 

Total 

The total estimated hours burden for 

both phases of the study ranges from 

303 hours (36 hours + 267 hours) to 454 

hours (54 hours + 400 hours). The hours 

burden due to the qualitative focus 

groups (40 hours) have not been 

included in this estimate because the 

focus groups will be completed under 

the current clearance.

William E. Kovacic, 

General Counsel.

[FR Doc. 04–21687 Filed 9–27–04; 8:45 am] 

BILLING CODE 6750–01–P

FEDERAL TRADE COMMISSION

Granting of Request for Early 

Termination of the Waiting Period 

Under the Premerger Notification 

Rules 

Section 7A of the Clayton Act, 15 

U.S.C. 18a, as added by Title II of the 

Hart-Scott-Rodino Antitrust 

Improvements Act of 1976, requires 

persons contemplating certain mergers 

or acquisitions to give the Federal Trade 

Commission and the Assistant Attorney 

General advance notice and to wait 

designated periods before 

consummation of such plans. Section 

7A(b)(2) of the act permits the agencies, 

in individual cases, to terminate this 

waiting period prior to its expiration 

and requires that notice of this action be 

published in the Federal Register. 

The following transactions were 

granted early termination of the waiting 

period provided by law and the 

premerger notification rules. The grants 

were made by the Federal Trade 

Commission and the Assistant Attorney 

General for the Antitrust Division of the 

Department of Justice. Neither agency 

intends to take any action with respect 

to these proposed acquisitions during 

the applicable waiting period.

Trans No. Acquiring Acquired Entities 

Transactions Granted Early Termination—08/16/2004

20041201 ......................... Carlyle Partners III, L.P. .................... Piedmont/Hawthorne Holdings, L.L.C Piedmont/Hawthorne Holdings, 

L.L.C. 

20041218 ......................... Tiger Key Acquisition, L.P. ................ KAC Mezzanine Holdings Company KAC Mezzanine Holdings Company. 

20041219 ......................... Tiger Key Acquisition, L.P. ................ KSS Holdings, Inc. ............................ KSS Holdings, Inc. 

20041228 ......................... TA IX L.P. .......................................... GlobeOp Financial Services S.A. ...... GlobeOp Financial Services S.A. 

20041229 ......................... Flextronics International Ltd .............. Nortel Networks Corporation ............. Nortel Networks Limited, Nortel Networks S.A., Nortel Networks Tele. 

do Brasil Comercio e Servicos 

Ltda., Nortel Networks Tele. do 

Brasil Industria e Comeercio Ltda., 

Nortel Networks UK Limited. 

20041233 ......................... The Warnaco Group, Inc. .................. Doyle & Boissiere Fund I, LLC. ........ Ocean Pacific Apparel Corp. 

20041236 ......................... Mervyn’s Holding, LLC. ..................... Target Corporation ............................ Mervyn’s, Mervyn’s Brand. 

20041238 ......................... Public Service Enterprise Group Incorporated.TECO Energy, Inc. ............................ TPS Holdings II, Inc. 

20041240 ......................... J.M. Huber Corporation ..................... Lehman FG, LLC. .............................. CP Kelco ApS. 

20041243 ......................... Nautic Partners V, L.P. ..................... Francis G.Hickey, Jr. ......................... Manhattan Digital Corporation. 

20041256 ......................... West Virginia United Health System, 

Inc..

Gateway Regional Health System, 

Inc..

Gateway Regional Health System, 

Inc. 

Transactions Granted Early Termination—08/17/2004

20041245 ......................... Wachovia Corporation ....................... Venturi Partners, Inc. ........................ Venturi Partners, Inc. 

20041254 ......................... ASP III Alternative Investments, L.P. Reservoir Capital Master Fund, L.P. RQ, LLC. 

20041267 ......................... Babcock & Brown Holdings Inc. ........ Babcock & Brown Associates LLC. .. Babcock & Brown Associates LLC. 

20041268 ......................... Babcock & Brown Associates LLC. .. Babcock & Brown Holdings Inc. ........ Babcock & Brown Holdings Inc. 

20041272 ......................... The PNC Financial Services Group, 

Inc..

Aviation Finance Group, LLC. ........... Aviation Finance Group, LLC. 

Transactions Granted Early Termination—08/18/2004

20041230 ......................... Carl C. Icahn ..................................... Mylan Laboratories, Inc. .................... Mylan Laboratories, Inc. 

20041231 ......................... James F. Dieberg .............................. Capital Resource Lenders II, L.P. ..... Loan Source Funding Corporation, 

Small Business Loan Source, Inc. 

20041242 ......................... 2003 Riverside Capital Appreciation 

Fund, L.P..

Code, Hennessy & Simmons III, L.P. United Central Industrial Supply 

Company, L.L.C. 

20041244 ......................... Quad-C Partners VI, L.P. .................. Dubin Clark Fund II, L.P. .................. Universal Trailer Holdings Corp. 

20041246 ......................... Western & Southern Mutual Holding 

Company.

Lafayette Life MIHC, Inc. .................. Lafayette Life MIHC, Inc. 

20041248 ......................... Clayton, Dubilier & Rice Fund VI 

Limited Partnership.

Veolia Environnement S.A. ............... APIC Filter GmbH, APIC SAS, 

Culligan Corporation, Culligan 

Espana, S.A., Culligan France 

SAS, Culligan International (UK) 

Limited, Culligan Italiana, S.p.A., 

Culligan N.V., Culligan of Canada, 

Ltd., Culligan Vostok, Culligan 

Wassertechnik, GmbH, US Filter 

Argentina S.A. 

Federal Register / Vol. 69, No. 187 / Tuesday, September 28, 2004 / Notices 57935

Trans No. Acquiring Acquired Entities 

20041249 ......................... Dynamics Research Corporation ...... CGW Southeast Partners IV, L.P. .... Impact Innovations Group LLC. 

20041252 ......................... Venturi Partners, Inc. ........................ Comsys Holding, Inc. ........................ Comsys Holding, Inc. 

20041264 ......................... Boral Limited ..................................... Ready Mixed Concrete Company 

(RMCC).

McKinney Concrete Products, LLC, 

Ready Mixed Concrete Company 

(RMCC), Sprat-Platte Ranch Co., 

LLLP. 

Transactions Granted Early Termination—08/19/2004

20041183 ......................... Verizon Communications, Inc. .......... Qwest Communications International 

Inc..

Qwest Wireless L.L.C. 

20041277 ......................... Joe Lewis Allbritton ........................... Riggs National Corporation ............... Riggs National Corporation. 

Transactions Granted Early Termination—08/20/2004

20041259 ......................... Avaya, Inc. ......................................... Spectel plc ......................................... Spectel plc. 

20041271 ......................... Carlyle Europe Partners II LP ........... Clariant Ltd. ....................................... Clariant Corporation 

20041275 ......................... ASP III Alternative Investments, L.P. Thomas L. Phillips ............................. Doctors’ Preferred, Inc., Phillips 

Health, LLC. 

20041279 ......................... William J. McEnery ............................ Don H. Barden .................................. Barden Colorado Gaming, LLC. 

20041282 ......................... New Enterprise Associates 10, L.P. Jeffrey Citron ..................................... Vonage Holdings Corporation. 

20041283 ......................... Wells Fargo & Company ................... Colleen D. Porterfield ........................ Bates Leasing Company, Ltd., MileHigh Deep Rock Water Company. 

20041284 ......................... Wells Fargo & Company ................... Roxanne F. Anderson ....................... Bates Leasing Company, Ltd., MileHigh Deep Rock Water Company. 

20041285 ......................... Long Point Capital Fund, L.P. ........... Bank of America Corporation ............ Savage Sports Corporation. 

20041293 ......................... Cooperatieve Centrale RaiffeisenBoerenleenbank B.A..Maize Acquisition Corporation .......... Farm Credit Services of America, 

FLCA; Farm Credit Services of 

America, PCA; Maize Acquisition 

Corporation; Maize Acquisition 

Corporation II (FLCA). 

20041295 ......................... Sumner M. Redstone ........................ SportsLine.com, Inc. .......................... SportsLine.com, Inc. 

20041299 ......................... Globix Corporation ............................ NEON Communications, Inc. ............ NEON Communications, Inc. 

20041301 ......................... ALLTEL Corporation .......................... ALLTEL Coropration .......................... Eau Claire Cellular Telephone Limited Partnership, Raleigh-Durham 

MSA Limited Partnership. 

Transactions Granted Early Termination—08/23/2004

20041200 ......................... Carlyle Partners III, L.P. .................... General Electric Company ................ GE Engine Services—Corporate 

Aviation, Inc. 

20041206 ......................... Medtronic, Inc. ................................... Coalescent Surgical, Inc. .................. Coalescent Surgical, Inc. 

20041216 ......................... Teva Pharmaceutical Industries Ltd .. Active Biotech AB .............................. Active Biotech AB. 

20041237 ......................... Gardner Denver, Inc. ......................... Audax Private Equity Fund, L.P. ....... nash_elmo Corp., nash_elmo Holdings LLC. 

20041269 ......................... Madison Dearborn Capital Partners 

IV, L.P..

Boise Cascade Corporation .............. BC Brazil Investment Corporation; 

BC Chile Investment Corp.; BCT, 

Inc.; BC China Corp.; Boise Alljoist 

Ltd.; Boise Building Products Limited; Boise Cascade do Brasil 

LTDA, Dr. Lauro Azambuja; Boise 

Cascade Corporation Chiles, S.A.; 

Boise Southern Company; Canada, Minnesota, Dakota & Western 

Railway Company; Compania Industrial Puerto Montt, S.A.; International Falls Power Company; 

Minidoka Paper Company. 

Transactions Granted Early Termination—08/24/2004

20041276 ......................... R.H. Donnelley Corporation .............. SBC Communications Inc. ................ APIL Partners Partnership, The Don 

Tech II Partnership. 

20041278 ......................... R.H. Donnelley Corporation .............. R.H. Donnelley Corporation .............. The AM–DON Partnership, The Don 

Tech II Partnership. 

0041297 ....................... Tootsie Roll Industries, Inc. ............... Concord Confections Inc. .................. Alpharetta Confections, Inc.; Concord Wax, LLC; Impel Movieline 

Inc.; Terra Rouge Estates Inc. 

20041298 ......................... Marathon Fund Limited Partnership 

IV.

VFI Holdings, Inc. .............................. Vitality Foodservice, Inc. 

Transactions Granted Early Termination—08/25/2004

20041208 ......................... Flextronics International Ltd. ............. Northfield Acquisition Co. .................. Northfield Acquisition Co. 

57936 Federal Register / Vol. 69, No. 187 / Tuesday, September 28, 2004 / Notices 

Trans No. Acquiring Acquired Entities 

20041239 ......................... Regal-Beloit Corporation ................... General Electric Company ................ GE Industrial Systems Mexico LP, 

GE Industrial Systems Technology 

Management, Inc. 

Transactions Granted Early Termination—08/26/2004

20041250 ......................... The Garfield Weston Charitable 

Foundation.

Graeme R. Hart ................................. Burns, Philp Inc. 

20041260 ......................... The Garfield Weston Charitable 

Foundation.

Mr. Graeme R. Hart .......................... Tone Bros. Inc. 

20041262 ......................... The Sherwin-Williams Company ....... Bessemer Securities LLC. ................. Paint Sundry Brands Corporation. 

20041302 ......................... ALLTEL Corporation .......................... Telephone and Data Systems, Inc., 

Voting Trust.

Georgia RSA #12 Partnership. 

Transactions Granted Early Termination—08/27/2004

20040902 ......................... The Sherwin-Williams Company ....... Duron, Inc. ......................................... Duron, Inc. 

20041291 ......................... SLM Corporation ............................... Helios Education Foundation ............ Southwest Student Services Corporation. 

20041306 ......................... Bruckmann, Rosser, Sherrill & Co. II, 

L.P..

SPC Partners II, L.P. ......................... Totes Acquisition Corporation. 

20041307 ......................... CGW Southeast Partners IV, L.P. .... TRP Investors LP .............................. TruckPro, Inc. 

20041308 ......................... Citigroup Inc. ..................................... Knight Trading Group, Inc. ................ Knight Execution Partners LLC, 

Knight Financial Products LLC. 

20041310 ......................... KKR Millennium Fund L.P. ................ DLJ Merchant Banking Partners III, 

L.P..

Jostens Holding Corp. 

20041320 ......................... General Electric Company ................ W.D. Company, Inc. .......................... Dillard Asset Funding Company, Dillard Credit Card Master Trust I, 

Dillard National Bank, Dillard’s, 

Inc. 

Transactions Granted Early Termination—09/01/2004

20041289 ......................... FedEx Corporation ............................ Quad/Graphics, Inc. .......................... Parcel Direct/DDU, Inc., Parcel Direct DDU, LLC, Parcel/Direct, Inc., 

Parcel Direct Logistics, Inc., Parcel 

Direct, LP. 

20041304 ......................... Caterpillar Inc. ................................... Remy International, Inc. .................... Williams Technologies, Inc. 

20041318 ......................... Mr. Bryan Gentry ............................... L’Air Liquide SA ................................. GT&S, LP. 

20041323 ......................... Alvarion Ltd ....................................... interWAVE Communications International Inc..interWAVE Communications International, Inc. 

Transactions Granted Early Termination—09/02/2004

20041255 ......................... Symbol Technologies, Inc. ................ Matrics, Inc. ....................................... Matrics, Inc. 

Transactions Granted Early Termination—09/03/2004

20041261 ......................... Raytheon Company ........................... Photon Research Associates, Inc. .... Photon Research Associates, Inc. 

20041327 ......................... Banco Santander Central Hispano, 

S.A..

Abbey National plc ............................ Abbey National plc. 

20041330 ......................... DEI Holdings, Inc. ............................. Sanford M. Gross .............................. Definitive Technology, LLP. 

20041339 ......................... Marquee Holdings, Inc. ..................... AMC Entertainment Inc. .................... AMC Entertainment Inc. 

20041341 ......................... Macquarie Infrastructure Assets 

Trust.

Macquarie Bank Limited .................... Macquarie District Energy Holdings 

LLC, North America Capital Holdings Company. 

20041351 ......................... Tekelec .............................................. Steleus Group, Inc. ........................... Steleus Group, Inc. 

20041359 ......................... Caroline Hunt Trust Estate ................ BMC Industries, Inc. .......................... P.T. Vision-Ease Asia, Vision-Ease 

Canada Ltd., Vision-Ease Lens 

Europe Ltd., Vision-Ease Lens, 

Inc. 

Transactions Granted Early Termination—09/07/2004

20041135 ......................... General Dynamics Corporation ......... Thyssen-Bornemieza Continuity 

Trust.

TriPoint Global Communications Inc. 

20041326 ......................... Encore Medical Corporation .............. MPI Holdings, LLC. ........................... Empi, Inc. 

20041338 ......................... Green Field II, LLC. ........................... MMM Healthcare, Inc. ....................... MMM Healthcare, Inc. 

Transactions Granted Early Termination—09/08/2004

20041317 ......................... The Children’s Place Retail Stores, 

Inc..

The Walt Disney Company ............... TDS Franchising, LLC, The Disney 

Store, LLC. 

20041336 ......................... The McGraw-Hill Companies, Inc. .... Capital IQ, Inc. .................................. Capital IQ, Inc. 

Federal Register / Vol. 69, No. 187 / Tuesday, September 28, 2004 / Notices 57937

Trans No. Acquiring Acquired Entities 

20041348 ......................... AGL Resources Inc. .......................... American Electric Power Company, 

Inc..

Jefferson Island Storage & Hub 

L.L.C. 

20041349 ......................... Ainsworth Lumber Co., Ltd ............... Potlatch Corporation .......................... Potlatch Corporation. 

20041355 ......................... HKW Capital Partners II, L.P. ........... Maxon Corporation ............................ Maxon Corporation. 

Transactions Granted Early Termination—09/09/2004

20041322 ......................... Michael E. Heisley, Sr ....................... Ivaco Inc. ........................................... Ifastgroupe and Company, Limited 

Partnership, Ifastgroupe Realty 

Inc., IFC (Fasteners) Inc. 

Transactions Granted Early Termination—09/10/2004

20041292 ......................... The Pepsi Bottling Group, Inc. .......... Seltzer & Rydholm, Inc. .................... Seltzer & Rydholm, Inc. 

20041311 ......................... Merck & Co., Inc. .............................. DOV Pharmaceutical, Inc. ................. DOV Pharmaceutical Inc. 

FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay, Contact Representative; 

or Renee Hallman, Case Management 

Assistant, Federal Trade Commission, 

Premerger Notification Office, Bureau of 

Competition, Room H–303, Washington, 

DC 20580, (202) 326–3100.

By Direction of the Commission 

Donald S. Clark, 

Secretary.

[FR Doc. 04–21688 Filed 9–27–04; 8:45 am] 

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N–0045]

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

Health and Diet Survey—2004 

Supplement

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘Health and Diet Survey—2004 

Supplement’’ has been approved by the 

Office of Management and Budget 

(OMB) under the Paperwork Reduction 

Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Peggy Robbins, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: In the 

Federal Register of May 19, 2004 (69 FR 

28928), the agency announced that the 

proposed information collection had 

been submitted to OMB for review and 

clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0545. The 

approval expires on September 30, 

2007. A copy of the supporting 

statement for this information collection 

is available on the Internet at http://

www.fda.gov/ohrms/dockets.

Dated: September 22, 2004.

Jeffrey Shuren,

Assistant Commissioner for Policy.

[FR Doc. 04–21674 Filed 9–27–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004E–0023]

Determination of Regulatory Review 

Period for Purposes of Patent 

Extension; REYATAZ

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) has determined 

the regulatory review period for 

REYATAZ and is publishing this notice 

of that determination as required by 

law. FDA has made the determination 

because of the submission of an 

application to the Director of Patents 

and Trademarks, Department of 

Commerce, for the extension of a patent 

that claims that human drug product.

ADDRESSES: Submit written comments 

and petitions to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. Submit 

electronic comments to http://

www.fda.gov/dockets/ecomments.

FOR FURTHER INFORMATION CONTACT:

Claudia V. Grillo, Office of Regulatory 

Policy (HFD–013), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 240–453–6699.

SUPPLEMENTARY INFORMATION: The Drug 

Price Competition and Patent Term 

Restoration Act of 1984 (Public Law 98–

417) and the Generic Animal Drug and 

Patent Term Restoration Act (Public 

Law 100–670) generally provide that a 

patent may be extended for a period of 

up to 5 years so long as the patented 

item (human drug product, animal drug 

product, medical device, food additive, 

or color additive) was subject to 

regulatory review by FDA before the 

item was marketed. Under these acts, a 

product’s regulatory review period 

forms the basis for determining the 

amount of extension an applicant may 

receive.

A regulatory review period consists of 

two periods of time: A testing phase and 

an approval phase. For human drug 

products, the testing phase begins when 

the exemption to permit the clinical 

investigations of the drug becomes 

effective and runs until the approval 

phase begins. The approval phase starts 

with the initial submission of an 

application to market the human drug 

product and continues until FDA grants 

permission to market the drug product. 

Although only a portion of a regulatory 

review period may count toward the 

actual amount of extension that the 

Director of Patents and Trademarks may 

award (for example, half the testing 

phase must be subtracted as well as any 

time that may have occurred before the 

patent was issued), FDA’s determination 

of the length of a regulatory review 

period for a human drug product will 

include all of the testing phase and 

approval phase as specified in 35 U.S.C. 

156(g)(1)(B).

FDA recently approved for marketing 

the human drug product REYATAZ 

(atazanavir sulfate). REYATAZ is 

indicated in combination with other